REQUEST A DEMO
Total
USD $0.00
Search more companies

Valueadd Pharma Sp. z o.o. (Poland)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Pharmaceutical Preparation Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Department Stores | Scientific Research and Development Services | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Packaging and Labeling Services
Full name: Valueadd Pharma Sp. z o.o. Profile Updated: May 03, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Valueadd Pharma Sp. z o.o. is an enterprise located in Poland, with the main office in Warsaw. It operates in the Research and Development in Biotechnology (except Nanobiotechnology) industry. The company was established on March 03, 2017. A negative growth of 79.91% was recorded in its total assets.

Headquarters
Ul. Domaniewska 47/10
Warsaw; Mazowieckie; Postal Code: 02-672

Contact Details: Purchase the Valueadd Pharma Sp. z o.o. report to view the information.

Basic Information
Registered Capital:
Purchase the Valueadd Pharma Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Valueadd Pharma Sp. z o.o. report to view the information.
Incorporation Date:
March 03, 2017
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Valueadd Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating Profit/Loss (EBIT)
1.2%
EBITDA
1.2%
Net Profit/Loss for the Period
N/A
Total Assets
-79.91%
Total Equity
-79.91%
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?